EMCURE PHARMACEUTICALS
|
EMCURE PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹189 Cr | ₹181 Cr | ₹181 Cr | ₹181 Cr | ₹181 Cr |
Equity - Authorised | ₹250 Cr | ₹250 Cr | ₹250 Cr | ₹200 Cr | ₹200 Cr |
Equity - Issued | ₹189 Cr | ₹181 Cr | ₹181 Cr | ₹181 Cr | ₹181 Cr |
Equity Paid Up | ₹189 Cr | ₹181 Cr | ₹181 Cr | ₹181 Cr | ₹181 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | ₹12 Cr | ₹14 Cr | ₹15 Cr | ₹16 Cr | ₹12 Cr |
Total Reserves | ₹4,245 Cr | ₹2,757 Cr | ₹2,305 Cr | ₹1,791 Cr | ₹2,080 Cr |
Securities Premium | ₹785 Cr | ₹9.88 Cr | - | - | ₹84 Cr |
Capital Reserves | - | - | - | - | ₹1.29 Cr |
Profit & Loss Account Balance | ₹3,313 Cr | ₹2,634 Cr | ₹2,196 Cr | ₹1,695 Cr | ₹1,744 Cr |
General Reserves | ₹64 Cr | ₹64 Cr | ₹82 Cr | ₹80 Cr | ₹175 Cr |
Other Reserves | ₹83 Cr | ₹49 Cr | ₹27 Cr | ₹16 Cr | ₹76 Cr |
Reserve excluding Revaluation Reserve | ₹4,245 Cr | ₹2,757 Cr | ₹2,305 Cr | ₹1,791 Cr | ₹2,080 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹4,446 Cr | ₹2,952 Cr | ₹2,501 Cr | ₹1,988 Cr | ₹2,273 Cr |
Minority Interest | ₹195 Cr | ₹169 Cr | ₹149 Cr | ₹127 Cr | ₹95 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹186 Cr | ₹761 Cr | ₹737 Cr | ₹709 Cr | ₹694 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹255 Cr | ₹930 Cr | ₹677 Cr | ₹679 Cr | ₹686 Cr |
Term Loans - Institutions | - | ₹204 Cr | ₹359 Cr | ₹296 Cr | ₹357 Cr |
Other Secured | ₹-68 Cr | ₹-372 Cr | ₹-299 Cr | ₹-266 Cr | ₹-350 Cr |
Unsecured Loans | ₹3.53 Cr | ₹5.24 Cr | ₹6.90 Cr | ₹8.54 Cr | ₹10 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | ₹3.53 Cr | ₹5.24 Cr | ₹6.90 Cr | ₹8.54 Cr | ₹10 Cr |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹9.04 Cr | ₹41 Cr | ₹-60 Cr | ₹-73 Cr | ₹-108 Cr |
Deferred Tax Assets | ₹251 Cr | ₹210 Cr | ₹173 Cr | ₹206 Cr | ₹260 Cr |
Deferred Tax Liability | ₹260 Cr | ₹251 Cr | ₹113 Cr | ₹132 Cr | ₹151 Cr |
Other Long Term Liabilities | ₹565 Cr | ₹527 Cr | ₹181 Cr | ₹182 Cr | ₹221 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹48 Cr | ₹43 Cr | ₹40 Cr | ₹42 Cr | ₹66 Cr |
Total Non-Current Liabilities | ₹812 Cr | ₹1,377 Cr | ₹905 Cr | ₹868 Cr | ₹883 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹1,480 Cr | ₹1,309 Cr | ₹1,086 Cr | ₹1,125 Cr | ₹972 Cr |
Sundry Creditors | ₹1,480 Cr | ₹1,309 Cr | ₹1,086 Cr | ₹1,125 Cr | ₹972 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹548 Cr | ₹855 Cr | ₹712 Cr | ₹649 Cr | ₹972 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹12 Cr | ₹33 Cr | ₹17 Cr | ₹15 Cr | ₹12 Cr |
Interest Accrued But Not Due | ₹1.01 Cr | ₹15 Cr | ₹13 Cr | ₹6.36 Cr | ₹11 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹536 Cr | ₹807 Cr | ₹682 Cr | ₹627 Cr | ₹949 Cr |
Short Term Borrowings | ₹474 Cr | ₹947 Cr | ₹1,132 Cr | ₹1,085 Cr | ₹1,253 Cr |
Secured ST Loans repayable on Demands | ₹475 Cr | ₹949 Cr | ₹1,132 Cr | ₹1,085 Cr | ₹1,247 Cr |
Working Capital Loans- Sec | ₹475 Cr | ₹949 Cr | ₹1,132 Cr | ₹1,062 Cr | ₹1,247 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-476 Cr | ₹-950 Cr | ₹-1,132 Cr | ₹-1,062 Cr | ₹-1,241 Cr |
Short Term Provisions | ₹167 Cr | ₹99 Cr | ₹89 Cr | ₹106 Cr | ₹211 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹112 Cr | ₹53 Cr | ₹49 Cr | ₹62 Cr | ₹62 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹55 Cr | ₹46 Cr | ₹40 Cr | ₹44 Cr | ₹150 Cr |
Total Current Liabilities | ₹2,668 Cr | ₹3,210 Cr | ₹3,019 Cr | ₹2,965 Cr | ₹3,408 Cr |
Total Liabilities | ₹8,122 Cr | ₹7,709 Cr | ₹6,573 Cr | ₹5,947 Cr | ₹6,659 Cr |
ASSETS | |||||
Gross Block | ₹5,485 Cr | ₹5,092 Cr | ₹3,802 Cr | ₹3,472 Cr | ₹3,932 Cr |
Less: Accumulated Depreciation | ₹2,288 Cr | ₹1,968 Cr | ₹1,656 Cr | ₹1,428 Cr | ₹1,476 Cr |
Less: Impairment of Assets | - | - | - | - | ₹44 Cr |
Net Block | ₹3,197 Cr | ₹3,125 Cr | ₹2,147 Cr | ₹2,044 Cr | ₹2,412 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹124 Cr | ₹132 Cr | ₹404 Cr | ₹310 Cr | ₹222 Cr |
Non Current Investments | ₹19 Cr | ₹18 Cr | ₹25 Cr | ₹25 Cr | ₹0.00 Cr |
Long Term Investment | ₹19 Cr | ₹18 Cr | ₹25 Cr | ₹25 Cr | ₹0.00 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹19 Cr | ₹18 Cr | ₹25 Cr | ₹25 Cr | ₹0.00 Cr |
Long Term Loans & Advances | ₹161 Cr | ₹144 Cr | ₹114 Cr | ₹112 Cr | ₹219 Cr |
Other Non Current Assets | ₹12 Cr | ₹3.75 Cr | ₹40 Cr | ₹22 Cr | ₹8.53 Cr |
Total Non-Current Assets | ₹3,566 Cr | ₹3,449 Cr | ₹2,737 Cr | ₹2,523 Cr | ₹2,942 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹76 Cr | ₹300 Cr | - | - | - |
Quoted | ₹76 Cr | ₹39 Cr | - | - | - |
Unquoted | - | ₹260 Cr | - | - | - |
Inventories | ₹1,932 Cr | ₹1,525 Cr | ₹1,383 Cr | ₹1,449 Cr | ₹1,514 Cr |
Raw Materials | ₹447 Cr | ₹323 Cr | ₹379 Cr | ₹420 Cr | ₹402 Cr |
Work-in Progress | ₹265 Cr | ₹253 Cr | ₹152 Cr | ₹155 Cr | ₹154 Cr |
Finished Goods | ₹319 Cr | ₹235 Cr | ₹194 Cr | ₹231 Cr | ₹204 Cr |
Packing Materials | ₹102 Cr | ₹98 Cr | ₹103 Cr | ₹72 Cr | ₹63 Cr |
Stores  and Spare | ₹96 Cr | ₹81 Cr | ₹66 Cr | ₹57 Cr | ₹38 Cr |
Other Inventory | ₹703 Cr | ₹534 Cr | ₹489 Cr | ₹514 Cr | ₹653 Cr |
Sundry Debtors | ₹2,002 Cr | ₹1,859 Cr | ₹1,648 Cr | ₹1,309 Cr | ₹1,475 Cr |
Debtors more than Six months | ₹230 Cr | ₹241 Cr | ₹181 Cr | ₹152 Cr | ₹49 Cr |
Debtors Others | ₹1,868 Cr | ₹1,681 Cr | ₹1,517 Cr | ₹1,195 Cr | ₹1,475 Cr |
Cash and Bank | ₹165 Cr | ₹232 Cr | ₹458 Cr | ₹313 Cr | ₹524 Cr |
Cash in hand | ₹0.11 Cr | ₹0.16 Cr | ₹0.18 Cr | ₹0.12 Cr | ₹0.39 Cr |
Balances at Bank | ₹165 Cr | ₹232 Cr | ₹458 Cr | ₹313 Cr | ₹523 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹85 Cr | ₹99 Cr | ₹79 Cr | ₹86 Cr | ₹34 Cr |
Interest accrued on Investments | - | - | - | - | ₹1.13 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹33 Cr | ₹30 Cr | ₹20 Cr | ₹33 Cr | ₹16 Cr |
Other current_assets | ₹53 Cr | ₹69 Cr | ₹59 Cr | ₹53 Cr | ₹17 Cr |
Short Term Loans and Advances | ₹295 Cr | ₹239 Cr | ₹268 Cr | ₹267 Cr | ₹170 Cr |
Advances recoverable in cash or in kind | ₹63 Cr | ₹68 Cr | ₹84 Cr | ₹115 Cr | ₹47 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹233 Cr | ₹171 Cr | ₹184 Cr | ₹151 Cr | ₹123 Cr |
Total Current Assets | ₹4,556 Cr | ₹4,254 Cr | ₹3,836 Cr | ₹3,424 Cr | ₹3,717 Cr |
Net Current Assets (Including Current Investments) | ₹1,888 Cr | ₹1,044 Cr | ₹817 Cr | ₹459 Cr | ₹309 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹8,122 Cr | ₹7,709 Cr | ₹6,573 Cr | ₹5,947 Cr | ₹6,659 Cr |
Contingent Liabilities | ₹394 Cr | ₹286 Cr | ₹97 Cr | ₹12 Cr | ₹13 Cr |
Total Debt | ₹731 Cr | ₹2,072 Cr | ₹2,182 Cr | ₹2,077 Cr | ₹2,310 Cr |
Book Value | 234.02 | 162.17 | 137.48 | 109.02 | 125.04 |
Adjusted Book Value | 234.02 | 162.17 | 137.48 | 109.02 | 125.04 |
Compare Balance Sheet of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹26,729.9 Cr | -0.1% | 12.5% | 3.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,373.0 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,285.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | -0.1% |
12.5% |
3.4% |
SENSEX | 0.2% |
-2.7% |
-0.9% |
You may also like the below Video Courses